These outcomes exceed the results seen in Phase 3 trials for semaglutide 2.4 mg (Wegovy) and tirzepatide 15 mg (Mounjaro)
Schedule your non-surgical consultation or follow-up appointment with Dr
The investment in GLP-1 therapy, even when paying cash prices, can provide significant long-term health benefits for eligible patients
GLP-1 analogues are often prescribed for chronic conditions such as type 2 diabetes and obesity, which require ongoing, long-term management
Third, although existing studies consistently demonstrate beneficial effects on hepatic steatosis and inflammation, the lack of head-to-head mechanistic and biomarker-based comparisons restricts the ability to distinguish between different GLP-1RAs or combination therapies in terms of their molecular pathways, immunemetabolic regulatory efficiency, and predictive biomarkers of therapeutic response
has organized educational events supported by Ethicon for BOMSS members (honoraria received for educational events)